HomeLYRA • NASDAQ
add
Lyra Therapeutics Inc
Previous close
$5.21
Day range
$5.16 - $5.42
Year range
$1.96 - $6.79
Market cap
312.46M USD
Avg Volume
409.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 146.00K | 1,227.27% |
Operating expense | 4.36M | 263.39% |
Net income | -15.16M | -6.47% |
Net profit margin | -10.38K | 91.98% |
Earnings per share | -0.20 | 37.94% |
EBITDA | -16.39M | -20.38% |
Effective tax rate | -0.11% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 102.75M | 4.96% |
Total assets | 142.60M | 29.67% |
Total liabilities | 53.18M | 82.04% |
Total equity | 89.42M | — |
Shares outstanding | 59.74M | — |
Price to book | 3.34 | — |
Return on assets | -31.30% | — |
Return on capital | -39.83% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -15.16M | -6.47% |
Cash from operations | -19.06M | -56.68% |
Cash from investing | -2.36M | 96.36% |
Cash from financing | 18.92M | — |
Net change in cash | -2.50M | 96.76% |
Free cash flow | -12.89M | -84.30% |
About
Founded
2005
Headquarters
Website
Employees
88